uniQure: Some hope yet for bulls?

SixSigmaCapital

Mar 5

NIHR and DHSC in the UK are backing AMT-130

1 Comment

SixSigmaCapital

This article is also worth reading.

https://www.nytimes.com/2026/03/05/health/fda-drugs-rare-diseases-rfk-jr.html

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts